KITE - Kite Pharma, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - KITE (1510580)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
92 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P5+3+0+0+0
S63-1-3-2+3

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-09-25
KITETomasello ShawnChief Commercial OfficerS - Sale$179.66-4,20361,068-6%-$755,127
2017-09-25
KITEKim Helen SusanEVP, Business DevelopmentS - Sale$179.66-3,17121,693-13%-$569,714
M
2017-03-15
KITEMoore Timothy L.EVP, Technical OperationsS - Sale$118.01-11,73945,661-20%-$1,385,360
2017-09-25
KITEWiezorek JeffreySVP Clinical DevelopmentS - Sale$179.66-5,28325,824-17%-$949,164
2017-09-25
KITEChang David DEVP, R, D, Chief Medical OfficS - Sale$179.66-7,92757,423-12%-$1,424,196
2017-09-25
KITEJenkinson Paul LCFOS - Sale$179.66-94812,462-7%-$170,321
2017-09-25
KITEButitta Cynthia MCOOS - Sale$179.66-4,228121,567-3%-$759,619
2017-09-25
KITEBelldegrun ArieCOB, Pres, CEOS - Sale$179.66-26,3473,306,429-1%-$4,733,605
D
2017-08-10
KITEKim Helen SusanEVP, Business DevelopmentS - Sale+OE$120.09-6,25118,664-25%-$750,683
D
2017-08-10
KITEButitta Cynthia MCOOS - Sale+OE$120.72-15,000117,795-11%-$1,810,758
D
2017-08-08
KITEKim Helen SusanEVP, Business DevelopmentS - Sale+OE$119.56-79,94918,664-81%-$9,558,324
D
2017-08-03
KITEMoore Timothy L.EVP, Technical OperationsS - Sale+OE$110.06-6,00049,400-11%-$660,343
D
2017-08-01
KITEMoore Timothy L.EVP, Technical OperationsS - Sale+OE$107.69-12,00049,400-20%-$1,292,322
D
2017-07-31
KITEKim Helen SusanEVP, Business DevelopmentS - Sale+OE$109.28-26,64918,664-59%-$2,912,272
D
2017-07-10
KITEButitta Cynthia MCOOS - Sale+OE$103.09-15,000117,795-11%-$1,546,300
D
2017-07-03
KITEWiezorek JeffreySVP Clinical DevelopmentS - Sale+OE$104.32-10,00021,071-32%-$1,043,201
AD
2017-06-23
KITEButitta Cynthia MCOOS - Sale+OE$100.81-5,000117,795-4%-$504,033
2017-06-23
KITEButitta Cynthia MCOOS - Sale$100.81-5,000112,795-4%-$504,033
DM
2017-06-23
KITEWitte Owen N.DirS - Sale+OE$100.30-25,00076,250-25%-$2,507,500
2017-06-14
KITERuchefsky Steven BDirS - Sale$89.48-20,000205,426-9%-$1,789,574
M
2017-06-14
KITEChampsi FarahDirS - Sale$89.79-20,45063,664-24%-$1,836,200
D
2017-06-09
KITEButitta Cynthia MCOOS - Sale+OE$88.55-10,000117,795-8%-$885,491
M
2017-06-07
KITEDoumani RoyDirS - Sale$84.48-15,000175,082-8%-$1,267,255
D
2017-06-01
KITEKim Helen SusanEVP, Business DevelopmentS - Sale+OE$72.45-2,40018,664-11%-$173,880
2017-05-09
KITENussbaum RanDirP - Purchase$69.11+9,8324,582-187%+$679,4740
2017-05-10
KITEJenkinson Paul LCFOP - Purchase$72.59+3,45010,480+49%+$250,427+4
2017-05-09
KITERuchefsky Steven BDirP - Purchase$69.50+1,400225,426+1%+$97,300+4
2017-05-09
KITEBonderman DavidDirP - Purchase$68.94+50,0002,410,034+2%+$3,446,998+4
2017-05-09
KITEBelldegrun ArieCOB, Pres, CEOP - Purchase$68.57+17,0003,282,776+1%+$1,165,690+2
D
2017-05-01
KITEKim Helen SusanEVP, Business DevelopmentS - Sale+OE$82.12-2,40018,664-11%-$197,088+3-11
D
2017-05-01
KITEChang David DEVP, R, D, Chief Medical OfficS - Sale+OE$82.09-20,00050,165-29%-$1,641,744+3-11
M
2017-04-27
KITEChampsi FarahDirS - Sale$82.75-19,16884,114-19%-$1,586,064-2-2
D
2017-04-25
KITEButitta Cynthia MCOOS - Sale+OE$81.85-15,000117,795-11%-$1,227,690-1-2
M
2017-04-24
KITEChampsi FarahDirS - Sale$82.67-123,913103,282-55%-$10,244,0360-1
M
2017-04-13
KITEChampsi FarahDirS - Sale$82.42-115,376227,195-34%-$9,509,766-3-3
D
2017-04-03
KITEChang David DEVP, R, D, Chief Medical OfficS - Sale+OE$81.54-20,00050,165-29%-$1,630,866-2+4+7
D
2017-04-03
KITEKim Helen SusanEVP, Business DevelopmentS - Sale+OE$81.80-2,40018,664-11%-$196,320-2+4+7
D
2017-04-03
KITEButitta Cynthia MCOOS - Sale+OE$81.96-5,000117,795-4%-$409,798-2+4+7
D
2017-03-27
KITEButitta Cynthia MCOOS - Sale+OE$77.67-10,000117,795-8%-$776,7460-1+5
D
2017-03-09
KITEButitta Cynthia MCOOS - Sale+OE$80.78-21,118117,795-15%-$1,705,929+20-7
D
2017-03-01
KITEWiezorek JeffreySVP Clinical DevelopmentS - Sale+OE$75.01-18,00021,071-46%-$1,350,144-6-5-2
D
2017-03-01
KITEChang David DEVP, R, D, Chief Medical OfficS - Sale+OE$79.16-60,00050,165-54%-$4,749,441-6-5-2
D
2017-03-01
KITEDoumani RoyDirS - Sale+OE$74.46-18,800100,130-16%-$1,399,815-6-5-2
DM
2017-02-28
KITEKim Helen SusanEVP, Business DevelopmentS - Sale+OE$67.78-50,30018,664-73%-$3,409,411-6-5-2
DM
2017-02-27
KITEButitta Cynthia MCOOS - Sale+OE$73.46-38,882117,795-25%-$2,856,182-6-7-1
D
2017-02-01
KITEWiezorek JeffreySVP Clinical DevelopmentS - Sale+OE$51.21-1,50020,695-7%-$76,820-1-1+40
D
2017-01-31
KITEButitta Cynthia MCOOS - Sale+OE$50.56-10,000117,795-8%-$505,562-1+1+44
D
2017-01-06
KITEWiezorek JeffreySVP Clinical DevelopmentS - Sale+OE$50.00-1,50020,695-7%-$75,000-5-8+1
D
2017-01-06
KITEButitta Cynthia MCOOS - Sale+OE$50.13-10,000117,795-8%-$501,289-5-8+1
2016-12-20
KITEWiezorek JeffreySVP Clinical DevelopmentS - Sale$50.86-71615,095-5%-$36,416+4-2+4
2016-12-20
KITETomasello ShawnChief Commercial OfficerS - Sale$50.86-4,90149,635-9%-$249,265+4-2+4
2016-12-20
KITEKim Helen SusanEVP, Business DevelopmentS - Sale$50.86-9368,064-10%-$47,605+4-2+4
2016-12-20
KITEChang David DEVP, R, D, Chief Medical OfficS - Sale$50.86-1,78825,123-7%-$90,938+4-2+4
2016-12-20
KITEButitta Cynthia MCOOS - Sale$50.86-2,48292,995-3%-$126,235+4-2+4
2016-12-20
KITEBelldegrun ArieCOB, Pres, CEOS - Sale$50.86-3,4933,287,9760%-$177,654+4-2+4
D
2016-12-01
KITEWiezorek JeffreySVP Clinical DevelopmentS - Sale+OE$50.76-1,50031,829-5%-$76,134-5-15-9
D
2016-11-25
KITEButitta Cynthia MCOOS - Sale+OE$50.40-10,00095,477-9%-$504,015+4+10-6
D
2016-11-10
KITEButitta Cynthia MCOOS - Sale+OE$50.65-10,00095,477-9%-$506,467-3-1-11
D
2016-11-10
KITEWiezorek JeffreySVP Clinical DevelopmentS - Sale+OE$50.18-1,50015,811-9%-$75,270-3-1-11
D
2016-10-03
KITEWiezorek JeffreySVP Clinical DevelopmentS - Sale+OE$54.81-1,50015,811-9%-$82,214-1-2-26+33
D
2016-09-26
KITEButitta Cynthia MCOOS - Sale+OE$54.13-10,00095,477-9%-$541,300-1-3-18+37
D
2016-09-01
KITEWiezorek JeffreySVP Clinical DevelopmentS - Sale+OE$58.24-1,50015,811-9%-$87,362+2-3-6+26
D
2016-08-25
KITEButitta Cynthia MCOOS - Sale+OE$58.28-10,00095,477-9%-$582,775-10-6-3
DM
2016-08-12
KITEKim Helen SusanEVP, Business DevelopmentS - Sale+OE$60.27-35,9009,000-80%-$2,163,825-2-1-11-12
D
2016-08-01
KITEWiezorek JeffreySVP Clinical DevelopmentS - Sale+OE$56.90-1,50014,867-9%-$85,343+6+4+5-9
D
2016-07-25
KITEButitta Cynthia MCOOS - Sale+OE$50.94-10,00095,401-9%-$509,350+4+10+16-8
D
2016-07-01
KITEWiezorek JeffreySVP Clinical DevelopmentS - Sale+OE$50.00-1,50014,867-9%-$75,0070-7+9-13
DM
2016-06-23
KITEButitta Cynthia MCOOS - Sale+OE$50.71-20,00095,401-17%-$1,014,238+3+3+5-6
2016-06-06
KITEDoumani RoyDirS - Sale$58.04-14,000158,882-8%-$812,581-5-10-7-5
DM
2016-05-31
KITEWiezorek JeffreySVP Clinical DevelopmentS - Sale+OE$50.65-3,00014,867-17%-$151,949-5+3-9-11
D
2016-04-04
KITEButitta Cynthia MCOO, CFOS - Sale+OE$50.00-10,00095,401-9%-$500,000-4-6-20+3
D
2016-03-15
KITEWiezorek JeffreySVP Clinical DevelopmentS - Sale+OE$44.88-9,00014,867-38%-$403,943-1-5+13+23
D
2016-03-15
KITESproule Rizwana FVP Regulatory AffairsS - Sale+OE$45.27-8,50010,211-45%-$384,791-1-5+13+23
D
2016-03-15
KITERoberts Margo RChief Scientific OfficerS - Sale+OE$45.23-8,50610,655-44%-$384,766-1-5+13+23
D
2016-03-01
KITEButitta Cynthia MCOO, CFOS - Sale+OE$50.03-10,00095,401-9%-$500,300+5-5-6+13
D
2016-02-17
KITERoberts Margo RChief Scientific OfficerS - Sale+OE$45.06-9,6329,098-51%-$434,018-3-6-8+26
D
2016-02-17
KITESproule Rizwana FVP Regulatory AffairsS - Sale+OE$45.08-9,5678,741-52%-$431,279-3-6-8+26
D
2016-02-16
KITEWiezorek JeffreySVP Clinical DevelopmentS - Sale+OE$44.07-9,00013,742-40%-$396,652+3-4-5+31
D
2016-02-12
KITERoberts Margo RChief Scientific OfficerS - Sale+OE$64.16-18,7509,098-67%-$1,202,964+7+40+36
D
2016-02-02
KITEButitta Cynthia MCOO, CFOS - Sale+OE$50.13-1,90094,007-2%-$95,247-12-14+16+26
D
2016-02-01
KITEBetter MarcVP, Product SciencesS - Sale+OE$47.34-9,0007,688-54%-$426,036+3-12+13+23
D
2016-01-27
KITEButitta Cynthia MCOO, CFOS - Sale+OE$51.62-8,10094,007-8%-$418,128+3-1-6+16
D
2016-01-15
KITEWiezorek JeffreySVP Clinical DevelopmentS - Sale+OE$55.26-9,00013,742-40%-$497,379+2-9-12-12
DM
2016-01-15
KITESproule Rizwana FVP Regulatory AffairsS - Sale+OE$55.49-9,5678,741-52%-$530,831+2-9-12-12
D
2016-01-15
KITERoberts Margo RChief Scientific OfficerS - Sale+OE$55.22-6,1459,098-40%-$339,323+2-9-12-12
D
2016-01-04
KITEBetter MarcVP, Product SciencesS - Sale+OE$61.53-9,0007,688-54%-$553,788-8-16-27-18
D
2015-12-28
KITEButitta Cynthia MCOO, CFOS - Sale+OE$61.56-10,00094,007-10%-$615,599-2-3-31-21
D
2015-12-15
KITEWiezorek JeffreySVP Clinical DevelopmentS - Sale+OE$63.78-9,0006,342-59%-$573,989-1-1-14-21
D
2015-12-15
KITERoberts Margo RChief Scientific OfficerS - Sale+OE$63.76-6,1452,198-74%-$391,815-1-1-14-21
D
2015-12-15
KITESproule Rizwana FVP Regulatory AffairsS - Sale+OE$63.76-9,5672,941-76%-$609,994-1-1-14-21
D
2015-12-01
KITEBetter MarcVP, Product SciencesS - Sale+OE$76.31-9,0001,888-83%-$686,819-3-4-15-28
D
2015-11-27
KITEButitta Cynthia MCOO, CFOS - Sale+OE$86.45-15,00075,507-17%-$1,296,680-8-14-21-36

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top